A model to estimate the risk of breast cancer-related lymphedema: combinations of treatment-related factors of the number of dissected axillary nodes, adjuvant chemotherapy, and radiation therapy.
Identifieur interne : 001C90 ( PubMed/Checkpoint ); précédent : 001C89; suivant : 001C91A model to estimate the risk of breast cancer-related lymphedema: combinations of treatment-related factors of the number of dissected axillary nodes, adjuvant chemotherapy, and radiation therapy.
Auteurs : Myungsoo Kim [Corée du Sud] ; Seok Won Kim ; Sung Uk Lee ; Nam Kwon Lee ; So-Youn Jung ; Tae Hyun Kim ; Eun Sook Lee ; Han-Sung Kang ; Kyung Hwan ShinSource :
- International journal of radiation oncology, biology, physics [ 1879-355X ] ; 2013.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Aisselle, Antinéoplasiques hormonaux (usage thérapeutique), Facteurs de risque, Facteurs temps, Femelle, Fractionnement de la dose d'irradiation, Humains, Irradiation ganglionnaire (), Irradiation ganglionnaire (effets indésirables), Lymphadénectomie (effets indésirables), Lymphadénectomie (utilisation), Lymphoedème (diagnostic), Lymphoedème (épidémiologie), Lymphoedème (étiologie), Mastectomie partielle (), Mastectomie partielle (effets indésirables), Mastectomie radicale modifiée (), Mastectomie radicale modifiée (effets indésirables), Méthodes épidémiologiques, Radiothérapie adjuvante (effets indésirables), Radiothérapie adjuvante (utilisation), Sujet âgé, Sujet âgé de 80 ans ou plus, Traitement médicamenteux adjuvant (effets indésirables), Traitement médicamenteux adjuvant (utilisation), Tumeurs du sein ().
- MESH :
- diagnostic : Lymphoedème.
- effets indésirables : Irradiation ganglionnaire, Lymphadénectomie, Mastectomie partielle, Mastectomie radicale modifiée, Radiothérapie adjuvante, Traitement médicamenteux adjuvant.
- usage thérapeutique : Antinéoplasiques hormonaux.
- utilisation : Lymphadénectomie, Radiothérapie adjuvante, Traitement médicamenteux adjuvant.
- épidémiologie : Lymphoedème.
- étiologie : Lymphoedème.
- Adulte, Adulte d'âge moyen, Aisselle, Facteurs de risque, Facteurs temps, Femelle, Fractionnement de la dose d'irradiation, Humains, Irradiation ganglionnaire, Mastectomie partielle, Mastectomie radicale modifiée, Méthodes épidémiologiques, Sujet âgé, Sujet âgé de 80 ans ou plus, Tumeurs du sein.
English descriptors
- KwdEn :
- Adult, Aged, Aged, 80 and over, Antineoplastic Agents, Hormonal (therapeutic use), Axilla, Breast Neoplasms (therapy), Chemotherapy, Adjuvant (adverse effects), Chemotherapy, Adjuvant (utilization), Dose Fractionation, Epidemiologic Methods, Female, Humans, Lymph Node Excision (adverse effects), Lymph Node Excision (utilization), Lymphatic Irradiation (adverse effects), Lymphatic Irradiation (methods), Lymphedema (diagnosis), Lymphedema (epidemiology), Lymphedema (etiology), Mastectomy, Modified Radical (adverse effects), Mastectomy, Modified Radical (methods), Mastectomy, Segmental (adverse effects), Mastectomy, Segmental (methods), Middle Aged, Radiotherapy, Adjuvant (adverse effects), Radiotherapy, Adjuvant (utilization), Risk Factors, Time Factors.
- MESH :
- chemical , therapeutic use : Antineoplastic Agents, Hormonal.
- adverse effects : Chemotherapy, Adjuvant, Lymph Node Excision, Lymphatic Irradiation, Mastectomy, Modified Radical, Mastectomy, Segmental, Radiotherapy, Adjuvant.
- diagnosis : Lymphedema.
- epidemiology : Lymphedema.
- etiology : Lymphedema.
- methods : Lymphatic Irradiation, Mastectomy, Modified Radical, Mastectomy, Segmental.
- therapy : Breast Neoplasms.
- utilization : Chemotherapy, Adjuvant, Lymph Node Excision, Radiotherapy, Adjuvant.
- Adult, Aged, Aged, 80 and over, Axilla, Dose Fractionation, Epidemiologic Methods, Female, Humans, Middle Aged, Risk Factors, Time Factors.
Abstract
The development of breast cancer-related lymphedema (LE) is closely related to the number of dissected axillary lymph nodes (N-ALNs), chemotherapy, and radiation therapy. In this study, we attempted to estimate the risk of LE based on combinations of these treatment-related factors.
DOI: 10.1016/j.ijrobp.2013.02.018
PubMed: 23541809
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:23541809Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">A model to estimate the risk of breast cancer-related lymphedema: combinations of treatment-related factors of the number of dissected axillary nodes, adjuvant chemotherapy, and radiation therapy.</title><author><name sortKey="Kim, Myungsoo" sort="Kim, Myungsoo" uniqKey="Kim M" first="Myungsoo" last="Kim">Myungsoo Kim</name><affiliation wicri:level="1"><nlm:affiliation>Research Institute and Hospital, National Cancer Center, Goyang, Korea.</nlm:affiliation><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Research Institute and Hospital, National Cancer Center, Goyang</wicri:regionArea><wicri:noRegion>Goyang</wicri:noRegion></affiliation></author><author><name sortKey="Kim, Seok Won" sort="Kim, Seok Won" uniqKey="Kim S" first="Seok Won" last="Kim">Seok Won Kim</name></author><author><name sortKey="Lee, Sung Uk" sort="Lee, Sung Uk" uniqKey="Lee S" first="Sung Uk" last="Lee">Sung Uk Lee</name></author><author><name sortKey="Lee, Nam Kwon" sort="Lee, Nam Kwon" uniqKey="Lee N" first="Nam Kwon" last="Lee">Nam Kwon Lee</name></author><author><name sortKey="Jung, So Youn" sort="Jung, So Youn" uniqKey="Jung S" first="So-Youn" last="Jung">So-Youn Jung</name></author><author><name sortKey="Kim, Tae Hyun" sort="Kim, Tae Hyun" uniqKey="Kim T" first="Tae Hyun" last="Kim">Tae Hyun Kim</name></author><author><name sortKey="Lee, Eun Sook" sort="Lee, Eun Sook" uniqKey="Lee E" first="Eun Sook" last="Lee">Eun Sook Lee</name></author><author><name sortKey="Kang, Han Sung" sort="Kang, Han Sung" uniqKey="Kang H" first="Han-Sung" last="Kang">Han-Sung Kang</name></author><author><name sortKey="Shin, Kyung Hwan" sort="Shin, Kyung Hwan" uniqKey="Shin K" first="Kyung Hwan" last="Shin">Kyung Hwan Shin</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2013">2013</date><idno type="RBID">pubmed:23541809</idno><idno type="pmid">23541809</idno><idno type="doi">10.1016/j.ijrobp.2013.02.018</idno><idno type="wicri:Area/PubMed/Corpus">001C15</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001C15</idno><idno type="wicri:Area/PubMed/Curation">001C15</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001C15</idno><idno type="wicri:Area/PubMed/Checkpoint">001C15</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001C15</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">A model to estimate the risk of breast cancer-related lymphedema: combinations of treatment-related factors of the number of dissected axillary nodes, adjuvant chemotherapy, and radiation therapy.</title><author><name sortKey="Kim, Myungsoo" sort="Kim, Myungsoo" uniqKey="Kim M" first="Myungsoo" last="Kim">Myungsoo Kim</name><affiliation wicri:level="1"><nlm:affiliation>Research Institute and Hospital, National Cancer Center, Goyang, Korea.</nlm:affiliation><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Research Institute and Hospital, National Cancer Center, Goyang</wicri:regionArea><wicri:noRegion>Goyang</wicri:noRegion></affiliation></author><author><name sortKey="Kim, Seok Won" sort="Kim, Seok Won" uniqKey="Kim S" first="Seok Won" last="Kim">Seok Won Kim</name></author><author><name sortKey="Lee, Sung Uk" sort="Lee, Sung Uk" uniqKey="Lee S" first="Sung Uk" last="Lee">Sung Uk Lee</name></author><author><name sortKey="Lee, Nam Kwon" sort="Lee, Nam Kwon" uniqKey="Lee N" first="Nam Kwon" last="Lee">Nam Kwon Lee</name></author><author><name sortKey="Jung, So Youn" sort="Jung, So Youn" uniqKey="Jung S" first="So-Youn" last="Jung">So-Youn Jung</name></author><author><name sortKey="Kim, Tae Hyun" sort="Kim, Tae Hyun" uniqKey="Kim T" first="Tae Hyun" last="Kim">Tae Hyun Kim</name></author><author><name sortKey="Lee, Eun Sook" sort="Lee, Eun Sook" uniqKey="Lee E" first="Eun Sook" last="Lee">Eun Sook Lee</name></author><author><name sortKey="Kang, Han Sung" sort="Kang, Han Sung" uniqKey="Kang H" first="Han-Sung" last="Kang">Han-Sung Kang</name></author><author><name sortKey="Shin, Kyung Hwan" sort="Shin, Kyung Hwan" uniqKey="Shin K" first="Kyung Hwan" last="Shin">Kyung Hwan Shin</name></author></analytic><series><title level="j">International journal of radiation oncology, biology, physics</title><idno type="eISSN">1879-355X</idno><imprint><date when="2013" type="published">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Antineoplastic Agents, Hormonal (therapeutic use)</term><term>Axilla</term><term>Breast Neoplasms (therapy)</term><term>Chemotherapy, Adjuvant (adverse effects)</term><term>Chemotherapy, Adjuvant (utilization)</term><term>Dose Fractionation</term><term>Epidemiologic Methods</term><term>Female</term><term>Humans</term><term>Lymph Node Excision (adverse effects)</term><term>Lymph Node Excision (utilization)</term><term>Lymphatic Irradiation (adverse effects)</term><term>Lymphatic Irradiation (methods)</term><term>Lymphedema (diagnosis)</term><term>Lymphedema (epidemiology)</term><term>Lymphedema (etiology)</term><term>Mastectomy, Modified Radical (adverse effects)</term><term>Mastectomy, Modified Radical (methods)</term><term>Mastectomy, Segmental (adverse effects)</term><term>Mastectomy, Segmental (methods)</term><term>Middle Aged</term><term>Radiotherapy, Adjuvant (adverse effects)</term><term>Radiotherapy, Adjuvant (utilization)</term><term>Risk Factors</term><term>Time Factors</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Aisselle</term><term>Antinéoplasiques hormonaux (usage thérapeutique)</term><term>Facteurs de risque</term><term>Facteurs temps</term><term>Femelle</term><term>Fractionnement de la dose d'irradiation</term><term>Humains</term><term>Irradiation ganglionnaire ()</term><term>Irradiation ganglionnaire (effets indésirables)</term><term>Lymphadénectomie (effets indésirables)</term><term>Lymphadénectomie (utilisation)</term><term>Lymphoedème (diagnostic)</term><term>Lymphoedème (épidémiologie)</term><term>Lymphoedème (étiologie)</term><term>Mastectomie partielle ()</term><term>Mastectomie partielle (effets indésirables)</term><term>Mastectomie radicale modifiée ()</term><term>Mastectomie radicale modifiée (effets indésirables)</term><term>Méthodes épidémiologiques</term><term>Radiothérapie adjuvante (effets indésirables)</term><term>Radiothérapie adjuvante (utilisation)</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Traitement médicamenteux adjuvant (effets indésirables)</term><term>Traitement médicamenteux adjuvant (utilisation)</term><term>Tumeurs du sein ()</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antineoplastic Agents, Hormonal</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Chemotherapy, Adjuvant</term><term>Lymph Node Excision</term><term>Lymphatic Irradiation</term><term>Mastectomy, Modified Radical</term><term>Mastectomy, Segmental</term><term>Radiotherapy, Adjuvant</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Lymphoedème</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Irradiation ganglionnaire</term><term>Lymphadénectomie</term><term>Mastectomie partielle</term><term>Mastectomie radicale modifiée</term><term>Radiothérapie adjuvante</term><term>Traitement médicamenteux adjuvant</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Lymphatic Irradiation</term><term>Mastectomy, Modified Radical</term><term>Mastectomy, Segmental</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antinéoplasiques hormonaux</term></keywords><keywords scheme="MESH" qualifier="utilisation" xml:lang="fr"><term>Lymphadénectomie</term><term>Radiothérapie adjuvante</term><term>Traitement médicamenteux adjuvant</term></keywords><keywords scheme="MESH" qualifier="utilization" xml:lang="en"><term>Chemotherapy, Adjuvant</term><term>Lymph Node Excision</term><term>Radiotherapy, Adjuvant</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Lymphoedème</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Lymphoedème</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Axilla</term><term>Dose Fractionation</term><term>Epidemiologic Methods</term><term>Female</term><term>Humans</term><term>Middle Aged</term><term>Risk Factors</term><term>Time Factors</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Aisselle</term><term>Facteurs de risque</term><term>Facteurs temps</term><term>Femelle</term><term>Fractionnement de la dose d'irradiation</term><term>Humains</term><term>Irradiation ganglionnaire</term><term>Mastectomie partielle</term><term>Mastectomie radicale modifiée</term><term>Méthodes épidémiologiques</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Tumeurs du sein</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The development of breast cancer-related lymphedema (LE) is closely related to the number of dissected axillary lymph nodes (N-ALNs), chemotherapy, and radiation therapy. In this study, we attempted to estimate the risk of LE based on combinations of these treatment-related factors.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23541809</PMID><DateCreated><Year>2013</Year><Month>05</Month><Day>27</Day></DateCreated><DateCompleted><Year>2013</Year><Month>07</Month><Day>25</Day></DateCompleted><DateRevised><Year>2013</Year><Month>05</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-355X</ISSN><JournalIssue CitedMedium="Internet"><Volume>86</Volume><Issue>3</Issue><PubDate><Year>2013</Year><Month>Jul</Month><Day>01</Day></PubDate></JournalIssue><Title>International journal of radiation oncology, biology, physics</Title><ISOAbbreviation>Int. J. Radiat. Oncol. Biol. Phys.</ISOAbbreviation></Journal><ArticleTitle>A model to estimate the risk of breast cancer-related lymphedema: combinations of treatment-related factors of the number of dissected axillary nodes, adjuvant chemotherapy, and radiation therapy.</ArticleTitle><Pagination><MedlinePgn>498-503</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijrobp.2013.02.018</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0360-3016(13)00200-9</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">The development of breast cancer-related lymphedema (LE) is closely related to the number of dissected axillary lymph nodes (N-ALNs), chemotherapy, and radiation therapy. In this study, we attempted to estimate the risk of LE based on combinations of these treatment-related factors.</AbstractText><AbstractText Label="METHODS AND MATERIALS" NlmCategory="METHODS">A total of 772 patients with breast cancer, who underwent primary surgery with axillary lymph node dissection from 2004 to 2009, were retrospectively analyzed. Adjuvant chemotherapy (ACT) was performed in 677 patients (88%). Among patients who received radiation therapy (n=675), 274 (35%) received supraclavicular radiation therapy (SCRT).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">At a median follow-up of 5.1 years (range, 3.0-8.3 years), 127 patients had developed LE. The overall 5-year cumulative incidence of LE was 17%. Among the 127 affected patients, LE occurred within 2 years after surgery in 97 (76%) and within 3 years in 115 (91%) patients. Multivariate analysis showed that N-ALN (hazard ratio [HR], 2.81; P<.001), ACT (HR, 4.14; P=.048), and SCRT (HR, 3.24; P<.001) were independent risk factors for LE. The total number of risk factors correlated well with the incidence of LE. Patients with no risk or 1 risk factor showed a significantly lower 5-year probability of LE (3%) than patients with 2 (19%) or 3 risk factors (38%) (P<.001).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The risk factors associated with LE were N-ALN, ACT, and SCRT. A simple model using combinations of these factors may help clinicians predict the risk of LE.</AbstractText><CopyrightInformation>Copyright © 2013 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Myungsoo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Research Institute and Hospital, National Cancer Center, Goyang, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Seok Won</ForeName><Initials>SW</Initials></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Sung Uk</ForeName><Initials>SU</Initials></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Nam Kwon</ForeName><Initials>NK</Initials></Author><Author ValidYN="Y"><LastName>Jung</LastName><ForeName>So-Youn</ForeName><Initials>SY</Initials></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Tae Hyun</ForeName><Initials>TH</Initials></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Eun Sook</ForeName><Initials>ES</Initials></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Han-Sung</ForeName><Initials>HS</Initials></Author><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>Kyung Hwan</ForeName><Initials>KH</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>03</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Radiat Oncol Biol Phys</MedlineTA><NlmUniqueID>7603616</NlmUniqueID><ISSNLinking>0360-3016</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018931">Antineoplastic Agents, Hormonal</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018931" MajorTopicYN="N">Antineoplastic Agents, Hormonal</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001365" MajorTopicYN="N">Axilla</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017024" MajorTopicYN="N">Chemotherapy, Adjuvant</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000656" MajorTopicYN="N">utilization</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019583" MajorTopicYN="N">Dose Fractionation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004812" MajorTopicYN="N">Epidemiologic Methods</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008197" MajorTopicYN="N">Lymph Node Excision</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000656" MajorTopicYN="N">utilization</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015182" MajorTopicYN="N">Lymphatic Irradiation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015411" MajorTopicYN="N">Mastectomy, Modified Radical</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015412" MajorTopicYN="N">Mastectomy, Segmental</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018714" MajorTopicYN="N">Radiotherapy, Adjuvant</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000656" MajorTopicYN="N">utilization</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>11</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2013</Year><Month>01</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>02</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>7</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23541809</ArticleId><ArticleId IdType="pii">S0360-3016(13)00200-9</ArticleId><ArticleId IdType="doi">10.1016/j.ijrobp.2013.02.018</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Corée du Sud</li></country></list><tree><noCountry><name sortKey="Jung, So Youn" sort="Jung, So Youn" uniqKey="Jung S" first="So-Youn" last="Jung">So-Youn Jung</name><name sortKey="Kang, Han Sung" sort="Kang, Han Sung" uniqKey="Kang H" first="Han-Sung" last="Kang">Han-Sung Kang</name><name sortKey="Kim, Seok Won" sort="Kim, Seok Won" uniqKey="Kim S" first="Seok Won" last="Kim">Seok Won Kim</name><name sortKey="Kim, Tae Hyun" sort="Kim, Tae Hyun" uniqKey="Kim T" first="Tae Hyun" last="Kim">Tae Hyun Kim</name><name sortKey="Lee, Eun Sook" sort="Lee, Eun Sook" uniqKey="Lee E" first="Eun Sook" last="Lee">Eun Sook Lee</name><name sortKey="Lee, Nam Kwon" sort="Lee, Nam Kwon" uniqKey="Lee N" first="Nam Kwon" last="Lee">Nam Kwon Lee</name><name sortKey="Lee, Sung Uk" sort="Lee, Sung Uk" uniqKey="Lee S" first="Sung Uk" last="Lee">Sung Uk Lee</name><name sortKey="Shin, Kyung Hwan" sort="Shin, Kyung Hwan" uniqKey="Shin K" first="Kyung Hwan" last="Shin">Kyung Hwan Shin</name></noCountry><country name="Corée du Sud"><noRegion><name sortKey="Kim, Myungsoo" sort="Kim, Myungsoo" uniqKey="Kim M" first="Myungsoo" last="Kim">Myungsoo Kim</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001C90 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 001C90 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:23541809
|texte= A model to estimate the risk of breast cancer-related lymphedema: combinations of treatment-related factors of the number of dissected axillary nodes, adjuvant chemotherapy, and radiation therapy.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:23541809" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |